Pharmacologic, nonhormonal treatment of impotence. Evaluation of associated factors.
A group of impotent patients previously treated with Strychiomel was evaluated. Strychiomel is a compound of three drugs, yohimbine, thioridazine (Mellaril), and strychnine sulfate, each of which has a specific effect. The results suggest that the compound drug may be beneficial in the majority of patients (66.7%) when impotence occurs without hormonal or severe vascular or psychologic problems. Other factors such as age or presence of other simultaneous diseases do not appear to be significant when treatment with this multiaction drug (Strychiomel) is utilized.
D000328:Adult; D004338:Drug Combinations; D004341:Drug Evaluation; D007172:Erectile Dysfunction / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D013331:Strychnine / Q000627:therapeutic use*; D013881:Thioridazine / Q000627:therapeutic use*; D015016:Yohimbine / Q000627:therapeutic use*
D004338:Drug Combinations; D015016:Yohimbine; D013331:Strychnine; D013881:Thioridazine